| __timestamp | BeiGene, Ltd. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13035000 | 2819557000 |
| Thursday, January 1, 2015 | 8816000 | 4103728000 |
| Friday, January 1, 2016 | 1070000 | 4860427000 |
| Sunday, January 1, 2017 | 238387000 | 5872227000 |
| Monday, January 1, 2018 | 198220000 | 6710800000 |
| Tuesday, January 1, 2019 | 428212000 | 7863400000 |
| Wednesday, January 1, 2020 | 308874000 | 8497100000 |
| Friday, January 1, 2021 | 1176283000 | 16071700000 |
| Saturday, January 1, 2022 | 1415921000 | 12172900000 |
| Sunday, January 1, 2023 | 2458779000 | 13117200000 |
| Monday, January 1, 2024 | 14202000000 |
Unleashing the power of data
In the competitive world of biotechnology, Regeneron Pharmaceuticals, Inc. and BeiGene, Ltd. have been vying for dominance in annual revenue. Over the past decade, Regeneron has consistently outpaced BeiGene, boasting a staggering 1,000% higher revenue on average. Starting in 2014, Regeneron reported revenues of approximately $2.8 billion, while BeiGene was just beginning its journey with $13 million. Fast forward to 2023, and Regeneron has reached an impressive $13.1 billion, maintaining its lead. However, BeiGene has shown remarkable growth, increasing its revenue by over 18,000% to $2.5 billion. This growth trajectory highlights BeiGene's aggressive expansion and potential to challenge industry giants. As the biotech landscape evolves, these two companies exemplify the dynamic shifts and opportunities within the sector.
Eli Lilly and Company and BeiGene, Ltd.: A Comprehensive Revenue Analysis
Novo Nordisk A/S vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Johnson & Johnson or Regeneron Pharmaceuticals, Inc.?
AstraZeneca PLC vs BeiGene, Ltd.: Examining Key Revenue Metrics
Revenue Insights: Gilead Sciences, Inc. and BeiGene, Ltd. Performance Compared
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
BeiGene, Ltd. or Lantheus Holdings, Inc.: Who Leads in Yearly Revenue?
BeiGene, Ltd. vs Grifols, S.A.: Examining Key Revenue Metrics
Breaking Down Revenue Trends: BeiGene, Ltd. vs Bausch Health Companies Inc.
Revenue Insights: BeiGene, Ltd. and HUTCHMED (China) Limited Performance Compared
Revenue Showdown: BeiGene, Ltd. vs Xencor, Inc.